Skip to content
healthcare.dev

HERCESSI

NDC 69448-015, Trastuzumab-strf, injection, powder, lyophilized, for solution, from Accord BioPharma Inc..

Product NDC
69448-015
Status
Listed
Labeler
Accord BioPharma Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761346
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69448-015 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRASTUZUMAB-STRF150 mg/7.4mL

Pharmacologic classes

HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]

Package NDCNDC-11Package
69448-015-05694480015051 VIAL, SINGLE-DOSE in 1 CARTON (69448-015-05) / 7.4 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/285d2142-5bfa-401c-9246-7de21c4451af
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=69448-015

Use it

Look up 69448-015 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69448-015 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69448-015. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.